INS and cardiovascular disorder: These taxonomic findings are supported by multiple alterations in microbiota lipid metabolism during GAHT in our cohort, providing further insights into the implications of microbiota-lipid interactions on body composition, insulin sensitivity, inflammation, and cardiovascular disease risk.